THOMAS MCNERNEY & PARTNERS LP's Net Worth

-$1.73 Million

Estimate Recalculated Feb 7, 2024 03:59PM EST

Who is THOMAS MCNERNEY & PARTNERS LP?

THOMAS MCNERNEY & PARTNERS LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CLARUS THERAPEUTICS INC, Coley Pharmaceutical Group, Inc., ZOGENIX, INC., Clarus Therapeutics Holdings, Inc., and Ocera Therapeutics, Inc..

SEC CIK

THOMAS MCNERNEY & PARTNERS LP's CIK is 0001231291

Past Insider Trading and Trends

2010 was THOMAS MCNERNEY & PARTNERS LP's most active year for acquiring shares with 22 total transactions. THOMAS MCNERNEY & PARTNERS LP's most active month to acquire stocks was the month of October. 2010 was THOMAS MCNERNEY & PARTNERS LP's most active year for disposing of shares, totalling 15 transactions. THOMAS MCNERNEY & PARTNERS LP's most active month to dispose stocks was the month of March. 2013 saw THOMAS MCNERNEY & PARTNERS LP paying a total of $14,631,414.00 for 2,438,569 shares, this is the most they've acquired in one year. In 2022 THOMAS MCNERNEY & PARTNERS LP cashed out on 7,505,824 shares for a total of $18,989,734.72, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CLARUS THERAPEUTICS INC No price found

Investor

THOMAS MCNERNEY & PARTNERS LP owns 3,528 units of Common Stock. In the year 2022 THOMAS MCNERNEY & PARTNERS LP filed a total of 1 filing.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-68.25%
-3.75M
$2.53
-$9,494,867.36
1.75M
Apr 20
No matching records found

Coley Pharmaceutical Group, Inc. No price found

Investor

THOMAS MCNERNEY & PARTNERS LP owns 5,184,956 units of Common Stock. In the year 2005 THOMAS MCNERNEY & PARTNERS LP acquired a total of 2,776,818 shares in Coley Pharmaceutical Group, Inc., THOMAS also disposed a total of 1,003,680 shares of Coley Pharmaceutical Group, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-29.42%
-1.00M
—
—
2.41M
May 18
Form 4
∞
2.78M
—
—
2.78M
Aug 15
Form 3
—
0
—
—
0
No matching records found

ZOGENIX, INC. No price found

Investor

THOMAS MCNERNEY & PARTNERS LP owns 3,152,880 units of Common Stock. In the year 2010 THOMAS MCNERNEY & PARTNERS LP filed a total of 5 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.43M
$4.00
—
1.43M
Nov 29
Form 4
∞
1.73M
$4.00
—
1.73M
Nov 29
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Clarus Therapeutics Holdings, Inc. No price found

Investor

THOMAS MCNERNEY & PARTNERS LP owns 3,528 units of Common Stock. In the year 2021 THOMAS MCNERNEY & PARTNERS LP disposed a total of 3,752,912 shares of Clarus Therapeutics Holdings, Inc. equalling to $9,494,867.36.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
-68.25%
-3.75M
$2.53
-$9,494,867.36
1.75M
Apr 20
Form 3
—
0
—
—
0
No matching records found

Ocera Therapeutics, Inc. No price found

Investor

THOMAS MCNERNEY & PARTNERS LP owns 8,986,358 units of Common Stock and 2,438,569 units of Common Stock, par value $0.00001 per share. From 2011 to 2017 THOMAS MCNERNEY & PARTNERS LP acquired a total of 5,440,855 shares in Ocera Therapeutics, Inc. at a cost of $17,881,414.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4/A
∞
2.44M
$6.00
$14,631,414.00
2.44M
Feb 6 - Jul 15
Form 4
+24.10%
3M
$4.00
$3,250,000.00
15.46M
Apr 6
Form 3
—
0
—
—
0
No matching records found